- DESCRIPTION
- TABLE OF CONTENTS
- METHODOLOGY
- DOWNLOAD PDF
Animal Parasiticides Market by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry), End User (Veterinary Hospitals, Animal Farms, Home Care Settings), & Region - Global Forecast to 2031
USD 17.50 BN
MARKET SIZE, 2031
CAGR 6.2%
(2026-2031)
450
REPORT PAGES
400
MARKET TABLES
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The global animal parasiticides market, valued at USD 12.30 billion in 2025, stood at USD 12.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.2% from 2026 to 2031, culminating in a forecasted valuation of USD 17.50 billion by the end of the period. The market is fueled by the increasing cases of ecto- and endoparasites in companion and food-producing animals, growing focus on the preventive management of parasites, and the rising number of pet owners worldwide. Advances in the development of parasiticides, such as combination therapies and long-acting treatments, along with the growing awareness of the transmission of zoonotic diseases, are also fueling the adoption of effective parasite control measures.
KEY TAKEAWAYS
-
By Region
Latin America is expected to register the highest CAGR of 7.7% during the forecast period (2026-2031).
-
By Type
By type, the ectoparasiticides segment is expected to register the highest CAGR of 7.0% during the forecast period.
-
By Animal Type
By animal type, the companion animals segment accounted for the largest market share (57.8%) in 2025.
-
By End User
By end user, the veterinary hospitals & clinics segment dominated the market with a share of 61.1% in 2025.
-
Competitive Landscape - Key Players
Zoetis Services LLC, Merck & Co., Inc., and Elanco were identified as some of the star players in the animal parasiticides market, given their extensive global reach and comprehensive product portfolios.
-
Competitive Landscape - Startups
ECO - Animal Health Ltd., Biogénesis Bagó, and Chanelle Pharma, among others, have distinguished themselves among startups and SMEs due to their specialized veterinary expertise and focused product capabilities.
The animal parasiticides market is expanding rapidly. The major factors contributing to this growth are increased expenditure on pet healthcare, the rising awareness of the need for parasite prevention throughout the year, and the strong market receptivity to novel, easy-to-administer treatment solutions. Some new technologies defining the market are the long-acting and extended-release formulations, combination endectocide products that provide broad-spectrum parasite control in a single dose, and advanced topical and oral delivery mechanisms that not only increase drug efficacy but also make it easier for patients to follow the treatment regimen. Besides that, the increasing use of digital health tools and data analytics for preventive care and ensuring treatment adherence is making it easier for people to adopt products. Moreover, pharmaceutical companies, veterinary networks, and technology providers' widening partnerships are indications of the accelerated product development and commercialization activities resulting in the animal parasiticides market's continued growth.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
The effect on the consumer businesses in the animal parasiticides market is due to the rising focus on preventive pet care, the prevalence of parasitic infections, and the concerns about resistance and zoonotic transmission. Veterinary practices, animal healthcare firms, and pet care operators are becoming more and more reliant on safe, broad-spectrum, and long-acting parasiticide solutions that provide year-round protection, improve owner compliance, and provide better outcomes. The need to provide convenient, fast-acting, and comprehensive parasite control while adjusting to the changing patterns of parasites and treatment modalities based on lifestyle trends is fueling the adoption of innovative parasiticide solutions. The rising need for effective and reliable parasitic protection is fueling the reliance on innovative parasiticide solution providers, which has a significant influence on the market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Drivers
Impact
Level
-
Rising pet ownership and increased focus on preventive animal healthcare
-
Growing prevalence of ecto- and endoparasites
RESTRAINTS
Impact
Level
-
Strict regulations on parasiticide residues in food-producing animals
-
High cost of premium and combination parasiticide products
OPPORTUNITIES
Impact
Level
-
Development of long-acting, combination, and novel-delivery parasiticides
-
Expansion of parasiticide adoption in emerging markets
CHALLENGES
Impact
Level
-
Increasing parasite resistance to existing active ingredients
-
Stringent regulatory approval processes and varying regional compliance requirements
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The increasing number of pet owners across the globe, especially in urban and developing countries, along with the rising awareness of preventive animal healthcare, is a major driving factor for the animal parasiticides market. Pet owners and animal farmers are now focusing on the regular prevention of parasites to prevent costly treatments, losses, and zoonoses. This is further fueled by the development of veterinary care, rising disposable income, and the humanization of pets.
Market expansion in the livestock sector remains constrained because strict regulations that control parasiticide levels in food-producing animals create obstacles for market development. Regulatory bodies enforce maximum residue limits (MRLs) to ensure consumer food safety, which results in increased development costs and extended product approval periods, and limits the availability of specific active ingredients. Product launches become more challenging for manufacturers operating in multiple regions because they must deal with different regional regulations, which create additional compliance requirements, in turn limiting market growth for their products.
The market shows substantial potential to expand through the introduction of long-acting parasiticides, combination products, and upcoming delivery systems. Products that provide extended protection, target multiple parasites, and reduce dosing frequency improve compliance among animal owners and veterinarians. Premiumization and product differentiation in the parasiticides market will experience growth because of ongoing formulation technology advancements, which include sustained-release injectables and palatable oral formulations, along with the rising market presence of emerging economies.
The animal parasiticides market faces its main obstacle because parasites develop resistance against all current active ingredients. The repeated use of chemical classes has led to their decreased effectiveness against specific parasite populations, which are found in intensive livestock systems. The challenge requires higher R&D expenses while it delays product development, and the market requires integrated parasite management with active ingredient rotation and better surveillance systems to achieve sustainable growth.
ANIMAL PARASITICIDES MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
Provides a wide parasiticide portfolio for companion animals (e.g., Simparica, Revolution/Stronghold) and livestock, along with vaccines, diagnostics, and other animal health solutions marketed globally. | Enables broad, cross-species parasite control and improves preventive care and herd/clinic productivity through well-known and trusted brands. |
|
|
Develops and commercializes parasiticides such as the BRAVECTO range, including long-acting formulations for fleas, ticks, and internal parasites in pets and livestock worldwide. | Increases treatment adherence with extended-duration protection and reduces parasite load, supporting better outcomes for veterinarians and owners. |
|
|
Offers parasiticides for both companion and production animals, supported by strong global R&D capabilities and extensive distribution networks. | Delivers effective, preventive, and therapeutic parasite control across species and helps meet the everyday needs of veterinary practices in Asia Pacific. |
|
|
Supplies parasiticides as part of a broader veterinary pharmaceutical portfolio for pets and livestock, targeting fleas, ticks, mites, internal worms, and related conditions. | Improves animal health and farm efficiency by providing veterinarians and farmers with dependable parasite management options. |
|
|
Provides a diverse range of external and internal parasiticides for companion animals and livestock, backed by localized subsidiaries and regional R&D. | Offers region-tailored parasite control solutions that strengthen veterinary care and support consistent prevention and treatment. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The ecosystem in the animal parasiticides market consists of different players, each of whom is crucial to the development, distribution, and use of solutions for controlling parasites. At the top of the list are animal health firms that are developing and producing parasiticides for companion animals and farm animals. These are followed by veterinary distributors and practices like veterinary hospitals & clinics and animal farms, which are the main end users of these products. Emerging players include technology firms that are providing online platforms for monitoring treatment compliance and resistance.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
In?????? 2025, ectoparasiticides held the largest share of the animal parasiticides market because external parasites like fleas, ticks, and mites infest both companion animals and livestock. The ongoing need for preventive treatment solutions exists because these parasites remain present in the environment. The segment experienced growth because people widely adopted topical treatments, collars, and oral formulations to treat fleas and ticks. The market dominance of ectoparasiticides receives support from their common application in preventive care routines.
In 2025, the companion animal segment held the largest share of the animal parasiticides market because of the increased adoption of pets, which led to higher spending on preventive health treatments. The ongoing requirement for parasiticides results from companion animals receiving continuous flea and tick and internal parasite treatment throughout the year. The segment remains dominant because customers maintain high veterinarian contact while premium long-lasting products stay on the market and awareness about parasite diseases increases.
By end user, the animal parasiticides market is estimated to be dominated by veterinary hospitals and clinics, because these facilities serve as the main location for diagnosing parasites and prescribing their treatment. Veterinary doctors help pet owners and livestock farmers choose the right products and preventive treatments, resulting in them using more prescription-based and high-priced parasiticides through veterinary clinics. The combination of long-acting products and combination products, as well as the increase in preventive veterinary visits, has established veterinary hospitals and clinics as the leading centers for distributing and using parasiticide products.
REGION
Latin America to be fastest-growing region in global parasiticides market during forecast period
Latin America is projected to be the fastest-growing regional market for animal parasiticides, owing to livestock production intensification, rise in pet ownership, and consumer awareness regarding the significance of parasite control as well as preventive animal healthcare. Due to the region's warm climate, parasites proliferate throughout the year, which is why there is constant demand for both ecto and endoparasiticides. Better veterinary services, the use of sophisticated animal health products, and the coming together of global and regional animal health companies for increased investments also contribute to the acceleration of market growth in Latin America.
ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX
In the animal parasiticides market, Zoetis (Star) is supported by a wide range of ectoparasiticides, endoparasiticides, and endectocides for both companion and production animals in its portfolio. It is supported with the leadership of the company from the continued investment in R&D, product innovations, a global distribution and veterinary network that facilitates deep market penetration and brand loyalty. Meanwhile, Virbac (Emerging Leader) is turning out to be a great challenger, especially in the field of companion animal parasiticides, carrying the torch of a veterinary-led approach through the offerings of the company, differentiated formulations, and a progressive move to the new regional markets.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Zoetis Services LLC (US)
- Merck & Co., Inc. (US)
- Elanco (US)
- Boehringer Ingelheim International GmbH (Germany)
- Virbac (France)
- Vetoquinol (France)
- Dechra Pharmaceuticals PLC (UK)
- Phibro Animal Health Corporation (US)
- Norbrook (UK)
- Bimeda Corporate (Ireland)
- krka (Slovenia)
- Ourofino Saúde Animal (Brazil)
- Sequent (India)
- PetIQ, LLC (US)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 12.30 BN |
| Market Forecast in 2031 (Value) | USD 17.50 BN |
| Growth Rate | CAGR of 6.2% from 2026 to 2031 |
| Years Considered | 2024-2031 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Million/Billion), Volume (Thousand Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Related Segment & Geographic Reports | APAC Animal Parasiticides Market |
WHAT IS IN IT FOR YOU: ANIMAL PARASITICIDES MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Compared different key parasiticide types for animals, such as ectoparasiticides, endoparasiticides, and endectocides. Evaluated whether used for prevention or treatment, by animal type (pets versus livestock), and product differentiation among major companies. | Facilitated clarity into product maturity, usage dynamics, and demand gaps, thereby aiding in portfolio optimization, pricing decisions, and prioritized focus on high-growth parasiticide markets. |
| Company Information | Profiled major animal health firms such as Zoetis, MSD Animal Health, Boehringer Ingelheim, Elanco, Virbac, and major local players. | Assessed their product portfolios, R&D investments, manufacturing, and distribution networks. |
| Geographic Analysis | Carried out in-depth regional analysis in China, India, Japan, Australia, and Rest of APAC regarding the prevalence of parasitic diseases, farm animal density, and companion animal market trends. | Assisted in the development of regional strategies for finding the fastest-growing countries, the level of complexity for regulations, opportunities for localizations, and markets to pursue in the APAC region. |
RECENT DEVELOPMENTS
- July 2025 : Merck & Co., Inc. announced that the US FDA approved BRAVECTO QUANTUM, an extended-release injectable suspension administered once annually to provide treatment and protection for dogs against fleas and ticks.
- April 2025 : Zoetis Services LLC reported that the US FDA approved an expanded indication for Simparica Trio, a combination canine parasiticide that also prevents flea-transmitted tapeworm infections.
- April 2024 : Zoetis Services LLC and Phibro Animal Health Corporation entered into a definitive agreement under which Phibro acquired Zoetis’ medicated feed additive portfolio, including selected water-soluble products and related assets, for USD 350 million.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
TITLE
PAGE NO
1
INTRODUCTION
15
2
EXECUTIVE SUMMARY
3
PREMIUM INSIGHTS
4
MARKET OVERVIEW
4.1
INTRODUCTION
4.2
MARKET DYNAMICS
4.2.1
DRIVERS
4.2.2
RESTRAINTS
4.2.3
OPPORTUNITIES
4.2.4
CHALLENGES
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.1
INTRODUCTION
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN GLOBAL HEALTHCARE INDUSTRY
5.2.4
TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY
5.3
SUPPLY CHAIN ANALYSIS
5.4
VALUE CHAIN ANALYSIS
5.5
ECOSYSTEM ANALYSIS
5.6
PRICING ANALYSIS
5.6.1
AVERAGE SELLING PRICE TREND, BY COUNTRY (2023–2025)
5.6.2
AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE (2023–2025)
5.7
TRADE ANALYSIS
5.7.1
IMPORT SCENARIO (HS CODE 3004)
5.7.2
EXPORT SCENARIO (HS CODE 3004)
5.8
KEY CONFERENCES AND EVENTS, 2026–2027
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.10
INVESTMENT AND FUNDING SCENARIO
5.11
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
5.12
IMPACT OF 2025 US TARIFF – ANIMAL PARASITICIDES MARKET
5.12.1
INTRODUCTION
5.12.2
KEY TARIFF RATES
5.12.3
PRICE IMPACT ANALYSIS
5.12.4
IMPACT ON COUNTRIES/REGIONS
5.12.4.1
US
5.12.4.2
EUROPE
5.12.4.3
ASIA PACIFIC
5.12.5
IMPACT ON END-USE INDUSTRIES
5.12.5.1
VETERINARY HOSPITALS & CLINICS
5.12.5.2
ANIMAL FARMS
5.12.5.3
HOME CARE SETTINGS
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
LONG-ACTING/EXTENDED-RELEASE PARASITICIDES
6.1.2
NOVEL MULTI-PARASITE ORAL COMBINATIONS
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
PRECISION LIVESTOCK FARMING (PLF) SENSORS & WEARABLES
6.2.2
NANOBIOSENSORS & RAPID DIAGNOSTICS FOR PARASITES
6.3
ADJACENT TECHNOLOGIES
6.3.1
PRECISION PARASITE MANAGEMENT
6.3.2
ENTOMOPATHOGENIC FUNGI (EPF) FOR TICKS & ECTOPARASITES
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.5
PATENT ANALYSIS
6.6
FUTURE APPLICATIONS
6.7
IMPACT OF AI/GEN AI ON ANIMAL PARASITICIDES MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
BEST PRACTICES IN ANIMAL PARASITICIDES MARKET
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL PARASITICIDES MARKET
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ANIMAL PARASITICIDES MARKET
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.1.2
INDUSTRY STANDARDS
7.2
SUSTAINABILITY INITIATIVES
7.2.1
ENERGY-EFFICIENT SYSTEM DESIGN AND USE OF RECYCLABLE MATERIALS IN ANIMAL PARASITICIDE PRODUCTS
7.3
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.4
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE AND BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5
MARKET PROFITABILITY
9
ANIMAL PARASITICIDES MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
COMPARATIVE ASSESSMENT OF KEY ANIMAL PARASITICIDES TYPES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS BY VARIOUS COMPANIES
9.1
INTRODUCTION
9.2
GLOBAL VOLUME ANALYSIS OF ANIMAL PARASITICIDES, 2024–2031 (THOUSAND UNITS)
9.3
ECTOPARASITICIDES
9.3.1
POUR-ONS & SPOT-ONS
9.3.2
ORAL TABLETS
9.3.3
SPRAYS
9.3.4
DIPS
9.3.5
EAR TAGS
9.3.6
COLLARS
9.3.7
OTHER ECTOPARASITICIDES
9.4
ENDOPARASITICIDES
9.4.1
ORAL LIQUIDS
9.4.2
ORAL SOLIDS
9.4.3
INJECTABLES
9.4.3.1
STANDARD/SHORT-ACTING INJECTABLES
9.4.3.2
LONG-ACTING/EXTENDED-RELEASE INJECTABLES
9.4.4
FEED ADDITIVES
9.4.5
OTHER ENDOPARASITICIDES
9.5
ENDECTOCIDES
9.5.1
ORAL ENDECTOCIDES
9.5.2
INJECTABLE ENDECTOCIDES
9.5.3
TOPICAL ENDECTOCIDES
NOTE: OTHER ECTOPARASITICIDES INCLUDE SHAMPOOS, SOAPS, POWDERS, CREAMS, AND DUSTS. OTHER ENDOPARASITICIDES INCLUDE GELS AND ORAL PASTES.
10
ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
ANIMAL-WISE DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING ANIMAL PARASITICIDES ADOPTION IN DIVERSE INDUSTRIES
10.1
INTRODUCTION
10.2
COMPANION ANIMALS
10.2.1
DOGS
10.2.2
CATS
10.2.3
HORSES
10.2.4
OTHER COMPANION ANIMALS
10.3
LIVESTOCK
10.3.1
CATTLE
10.3.2
PIGS
10.3.3
POULTRY
10.3.4
SHEEP & GOATS
10.3.5
OTHER LIVESTOCK
NOTE: OTHER COMPANION ANIMALS INCLUDE RABBITS, REPTILES, FISH, BIRDS, AND SMALL MAMMALS LIKE MICE, HAMSTERS, GUINEA PIGS, AND HEDGEHOGS.
NOTE: OTHER LIVESTOCK INCLUDES AQUATIC ANIMALS.
11
ANIMAL PARASITICIDES MARKET, BY END USER (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION)
SECTOR-SPECIFIC ADOPTION DRIVERS, DEMAND DYNAMICS, AND MARKET POTENTIAL ACROSS EACH END-USE INDUSTRY
11.1
INTRODUCTION
11.2
VETERINARY HOSPITALS & CLINICS
11.3
ANIMAL FARMS
11.4
HOME CARE SETTINGS
12
ANIMAL PARASITICIDES MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – IN VALUE, USD MILLION & VOLUME IN THOUSAND UNITS)
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY COUNTRIES
12.1
INTRODUCTION
12.2
NORTH AMERICA
12.2.1
NORTH AMERICA VOLUME ANALYSIS – 2024–2031 (THOUSAND UNITS)
12.2.2
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.3
US
12.2.4
CANADA
12.3
EUROPE
12.3.1
EUROPE VOLUME ANALYSIS – 2024–2031 (THOUSAND UNITS)
12.3.2
MACROECONOMIC OUTLOOK FOR EUROPE
12.3.3
GERMANY
12.3.4
UK
12.3.5
FRANCE
12.3.6
ITALY
12.3.7
SPAIN
12.3.8
NETHERLANDS
12.3.9
REST OF EUROPE
12.4
ASIA PACIFIC
12.4.1
ASIA PACIFIC VOLUME ANALYSIS – 2024–2031 (THOUSAND UNITS)
12.4.2
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.3
JAPAN
12.4.4
CHINA
12.4.5
INDIA
12.4.6
AUSTRALIA
12.4.7
SOUTH KOREA
12.4.8
THAILAND
12.4.9
NEW ZEALAND
12.4.10
REST OF ASIA PACIFIC
12.5
LATIN AMERICA
12.5.1
LATIN AMERICA VOLUME ANALYSIS – 2024–2031 (THOUSAND UNITS)
12.5.2
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.3
BRAZIL
12.5.4
MEXICO
12.5.5
REST OF LATIN AMERICA
12.6
MIDDLE EAST & AFRICA
12.6.1
MIDDLE EAST & AFRICA VOLUME ANALYSIS – 2024–2031 (THOUSAND UNITS)
12.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.3
TURKEY
12.6.4
GCC COUNTRIES
12.6.4.1
KINGDOM OF SAUDI ARABIA (KSA)
12.6.4.2
UNITED ARAB EMIRATES (UAE)
12.6.4.3
OTHER GCC COUNTRIES
12.6.5
REST OF MIDDLE EAST & AFRICA
NOTE: REST OF EUROPE INCLUDES RUSSIA, PORTUGAL, POLAND, FINLAND, DENMARK, AUSTRIA, ICELAND, IRELAND, AND NORWAY. REST OF ASIA PACIFIC INCLUDES BANGLADESH, BHUTAN, NEPAL, SRI LANKA, THE PHILIPPINES, SINGAPORE, VIETNAM, TAIWAN, CAMBODIA, AND INDONESIA. REST
16
COMPETITIVE LANDSCAPE
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
16.1
OVERVIEW
16.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
16.3
REVENUE SHARE ANALYSIS OF KEY PLAYERS (2021-2025)
16.4
MARKET SHARE ANALYSIS,
16.4.1
US MARKET SHARE ANALYSIS,
16.4.2
EUROPE MARKET SHARE ANALYSIS,
16.5
PRODUCT COMPARATIVE ANALYSIS
16.5.1
ZOETIS SERVICES LLC (SIMPARICA)
16.5.2
ELANCO (COMFORTIS)
16.5.3
BOEHRINGER INGELHEIM INTERNATIONAL GMBH (NEXGARD)
16.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
16.6.1
STARS
16.6.2
EMERGING LEADERS
16.6.3
PERVASIVE PLAYERS
16.6.4
PARTICIPANTS
16.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
16.6.5.1
COMPANY FOOTPRINT
16.6.5.2
REGION FOOTPRINT
16.6.5.3
TYPE FOOTPRINT
16.6.5.4
ANIMAL TYPE FOOTPRINT
16.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
16.7.1
PROGRESSIVE COMPANIES
16.7.2
RESPONSIVE COMPANIES
16.7.3
DYNAMIC COMPANIES
16.7.4
STARTING BLOCKS
16.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
16.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
16.7.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
16.8
COMPANY VALUATION AND FINANCIAL METRICS
16.9
COMPETITIVE SCENARIO
16.9.1
PRODUCT LAUNCHES
16.9.2
DEALS
16.9.3
EXPANSIONS
16.9.4
OTHER DEVELOPMENTS
17
COMPANY PROFILES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN ANIMAL PARASITICIDES MARKET LANDSCAPE
17.1
KEY PLAYERS
17.1.1
ZOETIS SERVICES LLC
17.1.2
MERCK & CO., INC.
17.1.3
ELANCO
17.1.4
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
17.1.5
VIRBAC
17.1.6
CEVA
17.1.7
VETOQUINOL
17.1.8
DECHRA PHARMACEUTICALS PLC
17.1.9
PHIBRO ANIMAL HEALTH CORPORATION
17.1.10
NORBROOK
17.1.11
BIMEDA CORPORATE
17.1.12
KRKA
17.1.13
OUROFINO SAÚDE ANIMAL
17.1.14
SEQUENT
17.1.15
PETIQ, LLC
17.2
OTHER PLAYERS
17.2.1
ECO - ANIMAL HEALTH LTD
17.2.2
BIOGÉNESIS BAGÓ
17.2.3
CHANELLE PHARMA
17.2.4
KYORITSU SEIYAKU CORPORATION
17.2.5
ABBEY LABS
17.2.6
VETANCOUSA
17.2.7
ASHISH LIFE SCIENCE
17.2.8
HEBEI VEYONG PHARMACEUTICAL CO., LTD.
17.2.9
SMARTVET
17.2.10
CALIER
18
RESEARCH METHODOLOGY
18.1
RESEARCH DATA
18.1.1
SECONDARY DATA
18.1.1.1
KEY DATA FROM SECONDARY SOURCES
18.1.2
PRIMARY DATA
18.1.2.1
KEY DATA FROM PRIMARY SOURCES
18.1.2.2
KEY PRIMARY PARTICIPANTS
18.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
18.1.2.4
KEY INDUSTRY INSIGHTS
18.2
MARKET SIZE ESTIMATION
18.2.1
BOTTOM-UP APPROACH
18.2.2
TOP-DOWN APPROACH
18.2.3
BASE NUMBER CALCULATION
18.3
MARKET FORECAST APPROACH
18.3.1
SUPPLY SIDE
18.3.2
DEMAND SIDE
18.4
DATA TRIANGULATION
18.5
FACTOR ANALYSIS
18.6
RESEARCH ASSUMPTIONS
18.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
19
APPENDIX
19.1
DISCUSSION GUIDE
19.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
19.3
CUSTOMIZATION OPTIONS
19.3.1
PRODUCT ANALYSIS
19.3.2
COMPANY INFORMATION
19.3.3
GEOGRAPHIC ANALYSIS
19.3.4
COUNTRY LEVEL MARKET SHARE ANALYSIS
19.3.5
COUNTRY LEVEL VOLUME ANALYSIS
19.3.6
BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
19.3.7
ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
19.4
RELATED REPORTS
19.5
AUTHOR DETAILS
Methodology
This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.
Secondary Research
This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the animal parasiticides market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.
Primary Research
In the primary research process, a range of sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. Primary sources from the supply side included project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the animal parasiticides market. Primary sources from the demand side included R&D and product development teams at animal health companies, veterinary clinicians, procurement managers at veterinary hospitals and clinics, and purchasing heads across livestock farms and animal health distribution networks.
A breakdown of the primary respondents is provided below:
Note: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million. C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the animal parasiticides market was determined after data triangulation from three approaches, as mentioned below. After each approach, the weighted average of the three approaches was taken based on the level of assumptions used in each approach.
Animal Parasiticides Market: Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
Animal parasiticides or antiparasitics are medications used to prevent, mitigate, and treat internal and external parasitic infestations in companion and livestock animals. Parasiticides are usually categorized as endoparasiticides, ectoparasiticides, and endectocides. They are available in various formulations, such as oral liquids, tablets, injectables, pour-ons, spot-ons, drenches, ear tags, collars, and sprays. A parasiticide is selected depending on the type of parasite, type of animal, and the number of animals to be treated.
Key Stakeholders
- Animal Parasiticide Manufacturers
- Animal Parasiticide Distributors
- Animal Health R&D Companies
- Veterinary Clinics and Hospitals
- Veterinary Pharmaceutical Associations
- Veterinary Research Institutes and Universities
- Venture Capitalists and Investors
- Market Research and Consulting Firms
- Government Associations
Report Objectives
- To define, describe, segment, and forecast the animal parasiticides market by type, animal type, end user, and region
- To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market in five main regions (along with their respective key countries): North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players in the market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships
Available customizations:
With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:
Company Information
-
Detailed analysis and profiling of additional market players (up to 5)
Regional Analysis
-
Further breakdown of the Rest of Europe animal parasiticides market into Austria, Finland, Switzerland, and other countries
-
Further breakdown of the Rest of Latin America animal parasiticides market into Colombia, Chile, and other countries
Competitive Landscape
-
Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the animal parasiticides market
Competitive leadership mapping for established players in the US
⚡ Growth Signals
Personalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Animal Parasiticides Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Company
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Company
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnostics
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Still Researching the
Animal Parasiticides Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
Explore Animal Parasiticides Intelligence
Powered by 17 years of MarketsandMarkets intelligence
